Correlation Between Lipoprotein-Related Phospholipase A2 and Metabolic Syndrome

Area of Science:

• Biomarkers and Diagnostics
• Cardiovascular Health and Inflammation
• Metabolic Syndrome Research

Background:

• Lipoprotein-associated phospholipase A2 (Lp-PLA2) is a recognized biomarker for cardiovascular disease and inflammation.
• Metabolic syndrome is strongly linked to chronic inflammation.
• This study investigates the correlation between Lp-PLA2 levels and metabolic syndrome.

Purpose of the Study:

• To examine the relationship between Lp-PLA2 levels and metabolic syndrome in Chinese adults.
• To determine a predictive cut-off value for Lp-PLA2 in identifying metabolic syndrome.
• To explore sex and age-based differences in Lp-PLA2 levels.

Main Methods:

• Retrospective analysis of health check-up data from 3549 Chinese adults (18-50 years).
• Data included Lp-PLA2 levels, metabolic syndrome status, and clinical characteristics.
• Statistical analysis to assess correlations and differences based on sex and age.

Main Results:

• Mean age was 44.2 years, mean Lp-PLA2 was 589 IU/L, and metabolic syndrome prevalence was 22%.
• Significant differences in Lp-PLA2 levels were observed between males and females.
• Lp-PLA2 correlated with BMI, cholesterol, and triglycerides, showing potential as a metabolic syndrome indicator, particularly in females.

Conclusions:

• Lp-PLA2 may serve as a valuable biomarker for identifying individuals at risk of metabolic syndrome, especially females.
• Further research is warranted to explore Lp-PLA2's diagnostic and therapeutic potential for metabolic syndrome.